Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

Mise à jour : Il y a 5 ans
Référence : NCT00825058

Femme et Homme

Extrait

Primary objective : - To demonstrate the antidepressant efficacy on the Hamilton Depression Rating Scale of SR58611A 700mg/day compared with placebo in the treatment of patients with a recurrent major depressive episode. Secondary objectives: - To assess the safety profile of SR58611A 700 mg/d in comparison to placebo and to assess plasma concentrations of the active metabolite.


Critère d'inclusion

  • Major Depressive Disorders


Liens